SOVEREIGN SYSTEM
Report
- Report Number
- 2020664-2011-00062
- Event Type
- Injury
- Date Received
- September 14, 2011
- Date of Event
- July 27, 2011
- Report Date
- August 16, 2011
- Manufacturer
- ABBOTT MEDICAL OPTICS
- Product Code
- HQC
- PMA / PMN Number
- K981116
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- NURSE
Narratives
EVALUATION SUMMARY: THE SYSTEM WAS EVALUATED BY A FIELD SERVICE ENGINEER ON 8/25/2011, IT PASSED AND MET AMO STANDARDS. THE CUSTOMER HAS NOT RETURNED THE HANDPIECE THAT WAS USED IN PATIENT'S SURGICAL PROCEDURE. THE CUSTOMER ADVISED THAT THE HANDPIECE WILL NOT BE MADE AVAILABLE FOR INVESTIGATION UNLESS PATIENT TAKES ACTION THAT WARRANTS SO. AS OF 12/26/2011 AND 1/26/2012, ALTHOUGH REQUESTS WERE MADE OF THE CUSTOMER, THERE HAS BEEN NO UPDATES ON PATIENT'S SURGICAL OUTCOME OR INITIATION OF LEGAL ACTION ON THE PART OF THE PATIENT. THE CUSTOMER STATED THAT THEY WILL KEEP US INFORMED. SHOULD ADDITIONAL INFORMATION BE PROVIDED THAT CHANGES THE INFORMATION ALREADY PROVIDED BY AMO, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
(B)(4). INVESTIGATION IS STILL IN PROGRESS AND A SUPPLEMENTAL WILL BE SUBMITTED. AMO CONCOMITANT PRODUCTS USED DURING THE PROCEDURE: VITRECTOMY HANDPIECE, (B)(4), TIP MODEL: DIPLOMAT VITRECTOMY.
SURGEON REPORTED THAT VACUUM STAYED ON WHEN PHACO HANDPIECE WAS REMOVED WHICH CAUSED PT AN INADVERTENT IRIDECTOMY. F/U WITH AMO REP INDICATED THAT PT LOST ABOUT 80% OF THE IRIS. THE SCLERAL WOUND WAS CLOSED WITH 7 SUTURES. POST-OPERATIVE REPORTED RESIDUAL BLOOD IN ANTERIOR CHAMBER WHICH IS CONTRIBUTING TO SOME VISION LOSS. VISION LOSS ANTICIPATED TO BE TEMPORARY AND MAY RETURN AFTER DISSIPATION OF RESIDUAL BLOOD. ADD'L POST-OPERATIVE THERAPY WILL REQUIRE FREQUENT OFFICE VISITS. EXPECTED PT OUTCOME AT THIS TIME IS UNK.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SOVEREIGN SYSTEM | HQC | ABBOTT MEDICAL OPTICS | RSOV680300 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 72 YR |